Cargando…
Survival benefit of pancreatic metastasectomy of clear cell renal cell carcinoma
Autores principales: | Fang, Yuan, Tang, Min, Zhou, Wen-Tao, Lou, Wen-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940095/ https://www.ncbi.nlm.nih.gov/pubmed/31765357 http://dx.doi.org/10.1097/CM9.0000000000000500 |
Ejemplares similares
-
Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable
por: Vogl, U M, et al.
Publicado: (2006) -
Nine-year survival after iterative metastasectomies for renal cell carcinoma
por: de Oliveira, Tiago Ribeiro, et al.
Publicado: (2019) -
Clinicopathological characteristics and genetic alterations in clear cell carcinoma cells derived from Mullerian duct epithelium of the prostate
por: Chen, Shaoan, et al.
Publicado: (2022) -
Pancreatic Resections for Advanced M1-Pancreatic Carcinoma: The Value of Synchronous Metastasectomy
por: Seelig, S. K., et al.
Publicado: (2010) -
Role of metastasectomy in the management of renal cell carcinoma
por: Mikhail, Mark, et al.
Publicado: (2022)